PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Obstetrics & Gynecology, National Taiwan University (NTU) Hospital & College of Medicine, NTU, Taipei, Taiwan, Republic of China.\', \'National Institute of Cancer Research, National Health Research Institutes (NHRI), Tainan, Taiwan, Republic of China.\', \'National Institute of Infectious Diseases & Vaccinology, NHRI, Zhunan, Taiwan, Republic of China.\', \'Department & Graduate Institute of Microbiology & Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.\', \'Regenerative Medicine Research Group, Institute of Cellular & System Medicine, NHRI, Zhunan, Taiwan, Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/sctm.21-0021
?:doi
?:hasPublicationType
?:journal
  • Stem cells translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34008922
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.722
?:rankingScore_hIndex
  • 45
is ?:relation_isRelatedTo_publication of
?:title
  • Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all